Table 1.

Demographic characteristics of the patients with confirmed COVID‐19

	FVP group (n = 32)	LPV/RTV group (n = 31)	p
Age, years	50.97 ± 10.36	56.61 ± 15.75	0.100
Sex, male	20 (62.5)	16 (51.6)	0.450
Exposure history	10 (31.3)	18 (58.1)	0.044
Married	12 (37.5)	5 (16.1)	0.088
Smoking	1 (3.1)	3 (9.7)	0.237
Comorbidities
Any	11 (34.4)	18 (58.1)	0.079
Diabetes	4 (12.5)	9 (29.0)	0.129
Hypertension	4 (12.5)	13 (41.9)	0.011
Cardiovascular disease	2 (6.3)	7 (22.6)	0.082
Obesity	5 (15.6)	0 (0.0)	0.053
Chronic lung disease	1 (3.1)	0 (0.0)	0.999
Rheumatologic disorders	1 (3.1)	0 (0.0)	0.999
Thyroid disorders	1 (3.1)	0 (0.0)	0.999

Note: Values were expressed as mean ± SD or n (%).

Comparison between groups was performed using the t‐test or Fisher's exact test.

Abbreviations: FVP, favipiravir; LPV/RTV, lopinavir/ritonavir.